Human Pluripotent Stem Cells
Pluristyx provides human pluripotent stem cells (hPSC) for use in R&D activities. Please enquire for GMP grade cells suitable for use as a starting materials in clinical applications. All cell lines are registered with the U.S. National Institutes of Health (NIH) and are listed in the NIH Human Stem Cell Registry and are eligible for use in NIH funded research.
ESI hPSC: Pluristyx is a licensed supplier of the ESI-brand of pluripotent stem cells (ESI-017, ESI-035, ESI-049, ESI-051, ESI-053). These NIH-registered pluripotent stem cells were derived under GTP (Good Tissue Practices) and are suitable for use in R&D and in the development of cellular therapeutics.
Pluristyx wild-type and disease-affected hPSC: Pluristyx is a licensed supplier of wild-type and disease-affected pluripotent stem cell lines from the University of Michigan. These NIH-registered lines allow means of studying disease progression and disease treatment using therapeutics.
ESI human pluripotent stem cells were derived under GTP making them suitable for use in diagnostic and therapeutic applications. Pluristyx currently provides these cells for research use only, but please inquire for GMP grade cell banks for use in clinical applications
Pluripotent stem cell lines that are wild-type and genetically normal. These lines are NIH approved and available for use in R&D. The lines listed below are currently in inventory, but please see the full list of available cell lines and inquire for availability and lead times.